These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6546843)

  • 1. Oral thyroxine: variation in biologic action and tablet content.
    Sawin CT; Surks MI; London M; Ranganathan C; Larsen PR
    Ann Intern Med; 1984 May; 100(5):641-5. PubMed ID: 6546843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The equivalency of two L-thyroxine preparations.
    Hennessey JV; Burman KD; Wartofsky L
    Ann Intern Med; 1985 Jun; 102(6):770-3. PubMed ID: 3922270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical comparison of two levothyroxine sodium products.
    Blouin RA; Clifton GD; Adams MA; Foster TS; Flueck J
    Clin Pharm; 1989 Aug; 8(8):588-92. PubMed ID: 2504532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-thyroxine dosage: a reevaluation of therapy with contemporary preparations.
    Hennessey JV; Evaul JE; Tseng YC; Burman KD; Wartofsky L
    Ann Intern Med; 1986 Jul; 105(1):11-5. PubMed ID: 3087253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency of brand name and generic levothyroxine.
    Stoffer SS; Szpunar WE
    JAMA; 1980 Oct; 244(15):1704-5. PubMed ID: 7411829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study on the absolute and relative bioavailability of Synthroid and Levothroid, two brands of sodium levothyroxine.
    Maxon HR; Ritschel WA; Volle CP; Eldon MA; Chen IW; Fernandez MF; Cline J; Mayfield G
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):379-82. PubMed ID: 6688797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability of two oral L-thyroxine formulations after multiple dose administration in patients with hypothyroidism and its relation with therapeutic endpoints and dissolution profiles.
    Vaisman M; Spina LD; Eksterman LF; dos Santos MJ; Lima JS; Volpato NM; da Silva RL; de Brito AP; Noël F
    Arzneimittelforschung; 2001; 51(3):246-52. PubMed ID: 11304941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans.
    Fish LH; Schwartz HL; Cavanaugh J; Steffes MW; Bantle JP; Oppenheimer JH
    N Engl J Med; 1987 Mar; 316(13):764-70. PubMed ID: 3821822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gluten and Aluminum Content in Synthroid
    Espaillat R; Jarvis MF; Torkelson C; Sinclair B
    Adv Ther; 2017 Jul; 34(7):1764-1769. PubMed ID: 28649691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism.
    Dong BJ; Hauck WW; Gambertoglio JG; Gee L; White JR; Bubp JL; Greenspan FS
    JAMA; 1997 Apr; 277(15):1205-13. PubMed ID: 9103344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tablet formulation of levothyroxine is absorbed less well than powdered levothyroxine.
    Yamamoto T
    Thyroid; 2003 Dec; 13(12):1177-81. PubMed ID: 14751040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone levels after acute L-thyroxine loading in hypothyroidism.
    Valente WA; Goldiner WH; Hamilton BP; Wiswell JG; Mersey JH
    J Clin Endocrinol Metab; 1981 Sep; 53(3):527-9. PubMed ID: 7263838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotrophin augmentation after commencing thyroxine replacement in primary hypothyroidism.
    Ghose RR; Upadhyay HP
    Postgrad Med J; 1986 Jan; 62(723):11-4. PubMed ID: 3797360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro dissolution and in vivo bioavailability of commercial levothyroxine sodium tablets in the hypothyroid dog model.
    Wood RW; Martis L; Gillum AW; Roseman TJ; Lin L; Bernardo P
    J Pharm Sci; 1990 Feb; 79(2):124-7. PubMed ID: 2324959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Posologic equivalents of oral L-thyroxine in thyroid insufficiency (120 cases)].
    Ann Med Interne (Paris); 1983; 134(7):636-42. PubMed ID: 6666901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equivalence of various levothyroxine preparations.
    Fischer RG; Kibbe AH; Nicholas WC; Sbravati C; Read VH
    J Fam Pract; 1982 Mar; 14(3):591-3. PubMed ID: 7038029
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute effect of exogenous thyroxine dose on serum thyroxine and thyrotrophin levels in treated hypothyroid patients.
    Soppi E; Irjala K; Kaihola HL; Viikari J
    Scand J Clin Lab Invest; 1984 Jun; 44(4):353-6. PubMed ID: 6463564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect.
    Young WF; Gorman CA; Jiang NS; Machacek D; Hay ID
    Clin Pharmacol Ther; 1984 Dec; 36(6):781-7. PubMed ID: 6499357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
    Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
    Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
    Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
    BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.